Association between calcific aortic stenosis and hypercholesterolemia: Is there a need for a randomized controlled trial of cholesterol-lowering therapy?

Clinical Cardiology

Volumn 24, Issue 1, 2001, Pages 52-55

  Chui, M C K ^a   Newby, D E ^a   Panarelli, M ^a   Bloomfield, P ^a   Boon, N A ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Aortic stenosis; Case control study; Hypercholesterolemia

Indexed keywords

CHOLESTEROL; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

ADULT; AGED; AORTA VALVE CALCIFICATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENDER; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MITRAL VALVE REPLACEMENT; PATHOGENESIS;

EID: 0035158955     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960240109     Document Type: Article

References (18)

1. Characterization of the early lesion of "degenerative" valvular aortic stenosis: Histological and immunohistochemical studies
2. Reported frequency of coronary arterial narrowing by angiogram in patients with valvular aortic stenosis
3. Demographic characteristics of patients undergoing aortic valve replacement for stenosis: Relation to valve morphology
4. High prevalence of atherosclerosis in patients with aortic stenosis. Chance finding or causal link?
5. Cardiac valve calcification: Characterisation of patients with calcification of the mitral valve annulus or aortic valve
6. A case-control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis
7. Clinical factors associated with calcific aortic valve disease
8. Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia
9. Aortic stenosis in homozygous familial hypercholesterolaemia
10. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of "degenerative" valvular aortic stenosis
11. Regression of valvular aortic stenosis due to homozygous familial hypercholesterolaemia following plasmapheresis
12. Correlation of serum lipids, calcium and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients
13. Diabetes and hypercholesterolaemia among patients with calcific aortic stenosis
14. Cholesterol and triglyceride levels in congenital bicuspid aortic valve: Risk factors for aortic stenosis
15. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
16. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography
17. Progression of aortic stenosis: Role of age and concomitant coronary artery disease
18. ACC/AHA guidelines for the management of patients with valvular heart disease